These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
377 related items for PubMed ID: 29047345
1. Visual prognosis better in eyes with less severe reduction of visual acuity one year after onset of Leber hereditary optic neuropathy caused by the 11,778 mutation. Mashima Y, Kigasawa K, Shinoda K, Wakakura M, Oguchi Y. BMC Ophthalmol; 2017 Oct 18; 17(1):192. PubMed ID: 29047345 [Abstract] [Full Text] [Related]
2. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy? Mashima Y, Kigasawa K, Wakakura M, Oguchi Y. J Neuroophthalmol; 2000 Sep 18; 20(3):166-70. PubMed ID: 11001192 [Abstract] [Full Text] [Related]
3. Rapid visual recovery after coenzyme q10 treatment of leber hereditary optic neuropathy. Huang CC, Kuo HC, Chu CC, Kao LY. J Neuroophthalmol; 2002 Mar 18; 22(1):66. PubMed ID: 11937918 [No Abstract] [Full Text] [Related]
9. Visual Outcomes in Leber Hereditary Optic Neuropathy Patients With the m.11778G>A (MTND4) Mitochondrial DNA Mutation. Newman NJ, Carelli V, Taiel M, Yu-Wai-Man P. J Neuroophthalmol; 2020 Dec 18; 40(4):547-557. PubMed ID: 32969847 [Abstract] [Full Text] [Related]
10. Therapeutic Effects of Idebenone on Leber Hereditary Optic Neuropathy. Zhao X, Zhang Y, Lu L, Yang H. Curr Eye Res; 2020 Oct 18; 45(10):1315-1323. PubMed ID: 32111141 [Abstract] [Full Text] [Related]
11. Influence of mutation type on clinical expression of Leber hereditary optic neuropathy. Spruijt L, Kolbach DN, de Coo RF, Plomp AS, Bauer NJ, Smeets HJ, de Die-Smulders CE. Am J Ophthalmol; 2006 Apr 18; 141(4):676-82. PubMed ID: 16564802 [Abstract] [Full Text] [Related]
12. [Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy]. Barnils N, Mesa E, Muñoz S, Ferrer-Artola A, Arruga J. Arch Soc Esp Oftalmol; 2007 Jun 18; 82(6):377-80. PubMed ID: 17573650 [Abstract] [Full Text] [Related]
17. Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset. Newman NJ, Yu-Wai-Man P, Carelli V, Moster ML, Biousse V, Vignal-Clermont C, Sergott RC, Klopstock T, Sadun AA, Barboni P, DeBusk AA, Girmens JF, Rudolph G, Karanjia R, Taiel M, Blouin L, Smits G, Katz B, Sahel JA, LHON Study Group. Ophthalmology; 2021 May 18; 128(5):649-660. PubMed ID: 33451738 [Abstract] [Full Text] [Related]
18. Variant and clinical landscape of Leber hereditary optic neuropathy based on 1516 families with mtDNA variants in a tertiary centre. Zheng Y, Wang Y, Jiang Y, Wang J, Li S, Xiao X, Sun W, Wang P, Zhang Q, Jia X. Br J Ophthalmol; 2024 Aug 22; 108(9):1318-1327. PubMed ID: 38346855 [Abstract] [Full Text] [Related]